Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.
about
Mouse models of gene-environment interactions in schizophrenia.Pre-clinical models of neurodevelopmental disorders: focus on the cerebellumGenetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice.Dopamine neuron dependent behaviorsmediated by glutamate cotransmission.Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors.
P2860
Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Modeling resilience to schizop ...... el approach to drug discovery.
@ast
Modeling resilience to schizop ...... el approach to drug discovery.
@en
type
label
Modeling resilience to schizop ...... el approach to drug discovery.
@ast
Modeling resilience to schizop ...... el approach to drug discovery.
@en
prefLabel
Modeling resilience to schizop ...... el approach to drug discovery.
@ast
Modeling resilience to schizop ...... el approach to drug discovery.
@en
P2093
P2860
P356
P1476
Modeling resilience to schizop ...... el approach to drug discovery.
@en
P2093
Andra Mihali
Genevieve Kaunitz
Inna Gaisler-Salomon
Shreya Subramani
Stephen Rayport
P2860
P304
P356
10.1586/ERN.12.60
P577
2012-07-01T00:00:00Z